A
Angela Dispenzieri
Researcher at Mayo Clinic
Publications - 1212
Citations - 72269
Angela Dispenzieri is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Multiple myeloma & Amyloidosis. The author has an hindex of 117, co-authored 1107 publications receiving 60367 citations. Previous affiliations of Angela Dispenzieri include University of Rochester & Kyungpook National University Hospital.
Papers
More filters
Journal ArticleDOI
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma
Abdullah S. Al Saleh,Abdullah S. Al Saleh,M. Hasib Sidiqi,Morie A. Gertz,Eli Muchtar,Martha Q. Lacy,Rahma Warsame,Wilson I. Gonsalves,Taxiarchis Kourelis,William J. Hogan,Suzanne R. Hayman,Prashant Kapoor,Francis K. Buadi,Angela Dispenzieri,David Dingli,Shaji Kumar +15 more
TL;DR: Standardization of oxygenscan measurements will enable comparisons as well as collaborations between the different laboratories studying RBC rheology in SCD, and have the potential to become an important tool in the evaluation of new treatment strategies, personalized medicine and the prediction of complications inSCD.
Journal ArticleDOI
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
Matthew Ho,Saurabh Zanwar,Prashant Kapoor,Morie A. Gertz,Martha Q. Lacy,Angela Dispenzieri,Suzanne R. Hayman,David Dingli,Francis K. Baudi,Eli Muchtar,Nelson Leung,Taxiarchis Kourelis,Rahma Warsame,Amie Fonder,Lisa Hwa,Miriam Hobbs,Robert A. Kyle,S. Vincent Rajkumar,Shaji Kumar +18 more
TL;DR: The optimal duration of lenalidomide maintenance post-autologous stem cell transplant (ASCT) in multiple myeloma (MM), and choice of therapy at relapse post-maintenance, need further evaluation as discussed by the authors.
Journal ArticleDOI
Analysis of Outcome after Autologous Stem Transplantation in Patients with Newly Diagnosed Myeloma: Comparison of Different Induction Regimens.
Shaji Kumar,Martha Q. Lacy,Angela Dispenzieri,Suzanne R. Hayman,S. Vincent Rajkumar,Steven R. Zeldenrust,John A. Lust,Philip R. Greipp,Robert A. Kyle,Dennis A. Gastineau,Morie A. Gertz +10 more
TL;DR: The outcome of SCT following three different induction therapies for newly diagnosed MM, namely VAD, single agent Dex, and Thal-Dex did not observe any difference in the response rates including complete responses to SCT in the three groups with nearly all pts in each group achieving a response.
Journal ArticleDOI
Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis.
Jithma P. Abeykoon,Jonas Paludo,Angela Dispenzieri,Morie A. Gertz,David Dingli,Francis K. Baudi,Wilson I. Gonsalves,Robert A. Kyle,Martha Q. Lacy,Suzanne R. Hayman,Nelson Leung,Taxiarchis Kourelis,S. Vincent Rajkumar,Shaji Kumar,Prashant Kapoor +14 more
TL;DR: Of 3433 patients, 52 (1.5%) were 40 years or younger at the time of diagnosis, with evidence of male and lambda predominance at 60% and 73%, respectively, and weight loss, dyspnea, edema and fatigue were the most common symptoms.
Journal ArticleDOI
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma.
Marcella Kaddoura,David Dingli,Francis K. Buadi,Martha Q. Lacy,Morie A. Gertz,Angela Dispenzieri,Prashant Kapoor,Lisa Hwa,Amie Fonder,Miriam Hobbs,Suzanne R. Hayman,John A. Lust,Nelson Leung,Ronald S. Go,Yi Lin,Wilson I. Gonsalves,Taxiarchis Kourelis,Rahma Warsame,Robert A. Kyle,Stephen M. Broski,Vincent Rajkumar,Shaji Kumar +21 more
TL;DR: In this article, a PET/CT scan near day 100 post-ASCT is shown to be predictive of shorter TTP and overall survival in patients with multiple myeloma.